US 11,707,624 B2
Methods and systems for treating cardiovascular disease using an implantable electroacupuncture device
Jeffrey H. Greiner, Valencia, CA (US); David K. L. Peterson, Valencia, CA (US); and Chuladatta Thenuwara, Castaic, CA (US)
Assigned to Valencia Bioscience, Inc., Valencia, CA (US)
Filed by Valencia Bioscience, Inc., Valencia, CA (US)
Filed on May 18, 2021, as Appl. No. 17/323,821.
Application 14/669,155 is a division of application No. 13/622,653, filed on Sep. 19, 2012, granted, now 8,996,125, issued on Mar. 31, 2015.
Application 17/323,821 is a continuation of application No. 16/394,902, filed on Apr. 25, 2019, granted, now 11,013,921.
Application 16/394,902 is a continuation of application No. 15/421,267, filed on Jan. 31, 2017, granted, now 10,299,986, issued on May 28, 2019.
Application 15/421,267 is a continuation of application No. 14/805,346, filed on Jul. 21, 2015, granted, now 9,603,773, issued on Mar. 28, 2017.
Application 14/805,346 is a continuation of application No. 14/669,155, filed on Mar. 26, 2015, granted, now 9,433,788, issued on Sep. 6, 2016.
Claims priority of provisional application 61/626,339, filed on Sep. 23, 2011.
Claims priority of provisional application 61/606,995, filed on Mar. 6, 2012.
Claims priority of provisional application 61/609,875, filed on Mar. 12, 2012.
Claims priority of provisional application 61/672,257, filed on Jul. 16, 2012.
Claims priority of provisional application 61/672,661, filed on Jul. 17, 2012.
Claims priority of provisional application 61/673,254, filed on Jul. 19, 2012.
Claims priority of provisional application 61/674,691, filed on Jul. 23, 2012.
Claims priority of provisional application 61/676,275, filed on Jul. 26, 2012.
Prior Publication US 2021/0268287 A1, Sep. 2, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01); A61N 1/375 (2006.01); A61N 1/372 (2006.01); A61H 39/00 (2006.01); A61N 1/378 (2006.01)
CPC A61N 1/36114 (2013.01) [A61H 39/00 (2013.01); A61H 39/002 (2013.01); A61N 1/36117 (2013.01); A61N 1/36125 (2013.01); A61N 1/36175 (2013.01); A61N 1/3756 (2013.01); A61N 1/37205 (2013.01); A61N 1/37223 (2013.01); A61H 2201/01 (2013.01); A61N 1/36153 (2013.01); A61N 1/36157 (2013.01); A61N 1/3782 (2013.01); A61N 1/3787 (2013.01); Y10T 29/49002 (2015.01)] 20 Claims
OG exemplary drawing
 
12. An implantable stimulator for treating cardiovascular disease in a patient, comprising:
a housing;
a central electrode of a first polarity and centrally located on a first surface of the housing;
an annular electrode of a second polarity and that surrounds the central electrode on the first surface of the housing, the annular electrode being spaced apart from the central electrode; and
pulse generation circuitry located within the housing, the pulse generation circuitry configured to
generate stimulation sessions at a duty cycle that is less than 0.05, and
apply the stimulation sessions to a location, within the patient, that is associated with the cardiovascular disease;
wherein
the duty cycle is a ratio of T3 to T4, and
each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes.